Viracta Therapeutics
Viracta is committed to advancing new medicines based on its viral activation therapy approach to benefit patients. Learn more
Launch date
Employees
Market cap
AUD14.8m
Enterprise valuation
AUD6m (Public information from Sep 2024)
Share price
$0.22 VIRX
Encinitas California (HQ)
Authorizing premium user...